UK 279276

Drug Profile

UK 279276

Alternative Names: Corleukin NIF; Recombinant neutrophil inhibitory factor; rNIF

Latest Information Update: 27 Jun 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dendreon San Diego LLC
  • Class Neuroprotectants
  • Mechanism of Action CD11b antigen antagonists; CD18 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Stroke

Most Recent Events

  • 27 Jun 2002 Pfizer has terminated its license for UK 279276
  • 27 Jun 2002 Discontinued - Phase-II for Stroke in USA (IV-injection)
  • 07 May 2001 A clinical study has been added to the pharmacokinetics and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top